US20090124697A1 - Inhalation formulations of treprostinil - Google Patents

Inhalation formulations of treprostinil Download PDF

Info

Publication number
US20090124697A1
US20090124697A1 US12/232,611 US23261108A US2009124697A1 US 20090124697 A1 US20090124697 A1 US 20090124697A1 US 23261108 A US23261108 A US 23261108A US 2009124697 A1 US2009124697 A1 US 2009124697A1
Authority
US
United States
Prior art keywords
treprostinil
ut
disease
patients
dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/232,611
Inventor
Gilles Cloutier
James Crow
Michael Wade
Richard E. Parker
James E. Loyd
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United Therapeutics Corp
Original Assignee
United Therapeutics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US52962203P priority Critical
Priority to US11/012,723 priority patent/US8765813B2/en
Application filed by United Therapeutics Corp filed Critical United Therapeutics Corp
Priority to US12/232,611 priority patent/US20090124697A1/en
Assigned to UNITED THERAPEUTICS CORPORATION reassignment UNITED THERAPEUTICS CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LOYD, JAMES E., CROW, JAMES, PARKER, RICHARD E., WADE, MICHAEL, CLOUTIER, GILLES
Publication of US20090124697A1 publication Critical patent/US20090124697A1/en
Application status is Abandoned legal-status Critical

Links